-- 
Ipsen Gains 1.9% on Agreement to Sell Photocure’s Hexvix

-- B y   M a r t h e   F o u r c a d e
-- 
2011-09-27T07:04:40Z

-- http://www.bloomberg.com/news/2011-09-27/ipsen-gains-1-9-on-agreement-to-sell-photocure-s-hexvix.html
Ipsen SA (IPN)  rose as much as 1.9
percent at the start of Paris trading after saying it signed an
agreement to market and sell  PhotoCure ASA (PHO) ’s Hexvix, a product
for the diagnosis of bladder cancer.  To contact the editor responsible for this story:
Marthe Fourcade at 
 mfourcade@bloomberg.net  